PML-directed treatments
| Treatment . | Number of patients (n = 11) . |
|---|---|
| Single-agent therapy | |
| Cidofovir | 2 |
| IVIG | 1 |
| Olanzapine | 1 |
| Solu-Medrol | 1 |
| Donor leukocyte infusion | 1 |
| Multiagent therapy | |
| Mefloquine and mirtazapine | 2 |
| Mefloquine, mirtazapine, and donor leukocyte infusion | 1 |
| Cidofovir, donor leukocyte infusion, and IVIG | 1 |
| Cidofovir, acyclovir, brincidofovir, and interleukin-7 | 1 |
| Treatment . | Number of patients (n = 11) . |
|---|---|
| Single-agent therapy | |
| Cidofovir | 2 |
| IVIG | 1 |
| Olanzapine | 1 |
| Solu-Medrol | 1 |
| Donor leukocyte infusion | 1 |
| Multiagent therapy | |
| Mefloquine and mirtazapine | 2 |
| Mefloquine, mirtazapine, and donor leukocyte infusion | 1 |
| Cidofovir, donor leukocyte infusion, and IVIG | 1 |
| Cidofovir, acyclovir, brincidofovir, and interleukin-7 | 1 |